Lazarus Alon 4
4 · Werewolf Therapeutics, Inc. · Filed Jun 13, 2025
Insider Transaction Report
Form 4
Lazarus Alon
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-12+27,000→ 27,000 totalExercise: $1.29Exp: 2035-06-11→ Common Stock (27,000 underlying)
Footnotes (1)
- [F1]The option was granted on June 12, 2025. The shares underlying the option vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders following the grant date, subject to the reporting person's continued service as a director.